Merck & Company Inc annual free cash flow for fiscal TTM was $14.1 billion, an increase of 14.2% from $12.4 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | $14.1B | $12.4B | $18.1B | $9.1B | $14.7B | $9.7B | $5.6B | $10.0B | $8.3B | $4.6B | $8.8B | $11.1B | $5.5B | $10.1B | $8.1B | $10.7B | $9.1B | $1.9B | $5.3B | $6.0B | $5.8B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | $2.9B | $1.8B | $6.8B | $2.5B | $1.2B | $2.5B | $8.5B | $4.8B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More MRK metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding
All MRK financial statements → Interactive MRK charts →
About TickerBase · Data methodology & sources